178 related articles for article (PubMed ID: 2424142)
1. [Viral vaccines produced by gene technology and synthesis].
Hess RG
Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
[TBL] [Abstract][Full Text] [Related]
2. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
Brown F
Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
[No Abstract] [Full Text] [Related]
3. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D.
García-Briones MM; Blanco E; Chiva C; Andreu D; Ley V; Sobrino F
Virology; 2004 May; 322(2):264-75. PubMed ID: 15110524
[TBL] [Abstract][Full Text] [Related]
4. Recombinant DNA technology for the preparation of subunit vaccines.
Bachrach HL
J Am Vet Med Assoc; 1982 Nov; 181(10):992-9. PubMed ID: 6129235
[TBL] [Abstract][Full Text] [Related]
5. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
[TBL] [Abstract][Full Text] [Related]
6. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
7. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
Vasantha S; Antony A; Lal SM
Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides against foot-and-mouth disease--immunization with VP1-peptides of type O1-Kaufbeuren.
Liebermann H; Holl U; Reimann I; Nöckler A; Schäfer D; Thalmann G; Dölling R
Arch Exp Veterinarmed; 1990; 44(6):883-90. PubMed ID: 1966360
[TBL] [Abstract][Full Text] [Related]
9. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine.
Huang H; Yang Z; Xu Q; Sheng Z; Xie Y; Yan W; You Y; Sun L; Zheng Z
Viral Immunol; 1999; 12(1):1-8. PubMed ID: 10333237
[TBL] [Abstract][Full Text] [Related]
10. Virion proteins and the perspectives of gene manipulations in vaccine preparation.
Tickhonenko TI
Acta Virol; 1985 May; 29(3):254-65. PubMed ID: 2413750
[TBL] [Abstract][Full Text] [Related]
11. New approaches in viral vaccine development.
Brown F
Scand J Infect Dis Suppl; 1990; 76():39-46. PubMed ID: 1966307
[TBL] [Abstract][Full Text] [Related]
12. [Antigenic structure of the foot-and-mouth disease virus. II. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth disease virus type A22].
Vol'pina OM; Surovoĭ AIu; Ul'iashin VV; Ivanov VT; Chepurkin AV
Bioorg Khim; 1988 Oct; 14(10):1363-71. PubMed ID: 2852938
[TBL] [Abstract][Full Text] [Related]
13. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
Qian P; Li XM; Jin ML; Peng GQ; Chen HC
Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
[TBL] [Abstract][Full Text] [Related]
14. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
15. [Antigenic structure of the foot-and-mouth-disease virus. I. Synthesis of protective peptides from the major immunogenic region of VP1 protein of foot-and-mouth virus type O1K].
Surovoĭ AIu; Vol'pina OM; Snetkova EV; Volkova TD; Ivanov VT
Bioorg Khim; 1988 Oct; 14(10):1352-62. PubMed ID: 2852937
[TBL] [Abstract][Full Text] [Related]
16. The application of biotechnology to the control of foot-and-mouth disease virus.
Kitching RP
Br Vet J; 1992; 148(5):375-88. PubMed ID: 1330200
[TBL] [Abstract][Full Text] [Related]
17. [Chemosynthetic peptides against foot-and-mouth disease--immune response to free and carrier bound peptides of the VP1 of O1-Kaufbeuren].
Liebermann H; Reimann I; Bartels T; Nöckler A; Thalmann G; Furkert J; Dölling R
Arch Exp Veterinarmed; 1990; 44(2):189-97. PubMed ID: 1696803
[TBL] [Abstract][Full Text] [Related]
18. [Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22].
Onishchenko AM; Petrov NA; Blinov VM; Vasilenko SK; Sandakhchiev LS
Bioorg Khim; 1986 Mar; 12(3):416-9. PubMed ID: 2421736
[TBL] [Abstract][Full Text] [Related]
19. [Antigenic structure of the foot-and-mouth disease virus. III. Immunogenic properties of synthetic peptides of the sequence of the immunodominant region of VP1 proteins of the O1K and A22 strains of foot-and-mouth virus].
Surovoĭ AIu; Gel'fanov VM; Vol'pina OM; Ivanov VT; Chepurkin AV; Chepurkin AV; Ivaniushchenkov VM; Driagalin NN; Burdov AN
Bioorg Khim; 1989 Sep; 15(9):1185-92. PubMed ID: 2480134
[TBL] [Abstract][Full Text] [Related]
20. [Prospects and achievements of genetic engineering in development of antiviral vaccines].
Tikhonenko TI
Mol Biol (Mosk); 1984; 18(1):176-88. PubMed ID: 6323971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
